ImmunityBio founder Dr. Patrick Soon-Shiong met with Turkish President Recep Tayyip Erdogan to discuss the company’s planned expansion into Turkey’s cancer care market. News of the meeting helped lift ImmunityBio shares nearly 10% earlier in the week, as investors weighed the company’s growth strategy and execution of ANKTIVA, its FDA-approved therapy.
A new SEC filing shows that Bank of America Corp DE acquired a new stake in ImmunityBio during the second quarter. The bank purchased more than 2.18 million shares, valued at approximately $19.1 million.